Healthcare Wire Texas
SEE OTHER BRANDS

Exploring the health and wellness news of Texas

Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on June 5, 2025

Dental Assistant School of Houston Announces Summer 2025 Opening of New Conroe Location

Dental Assistant School of Houston Announces Summer 2025 Opening of New Conroe Location

Dental Assistant School of Houston opens a new Conroe location in June 2025! Train in 12 weeks, hands-on, and graduate debt-free. Limited spots—apply now! CONROE, TX, UNITED STATES, June 5, 2025 /⁨EINPresswire.com⁩/ -- Dental Assistant School of Houston …

Physical-Therapy-Assistant.org Rolls Out Major Updates to Help Students Find Accredited PTA Programs

Physical-Therapy-Assistant.org Rolls Out Major Updates to Help Students Find Accredited PTA Programs

New Features Make It Easier to Explore Local and Online Physical Therapist Assistant Programs AUSTIN, TX, UNITED STATES, June 5, 2025 /⁨EINPresswire.com⁩/ -- Physical-Therapy-Assistant.org, a leading online resource for individuals pursuing a career as a …

Midland Welcomes Dental Assistant School with Debt-Free Training

Midland Welcomes Dental Assistant School with Debt-Free Training

New school Midland Dental Assistant School offers a 12-week, hands-on program to train debt-free dental assistants in Midland, TX. Apply now—seats are limited! MIDLAND, TX, UNITED STATES, June 5, 2025 /⁨EINPresswire.com⁩/ -- Midland Dental Assistant …

DentTracks Unveils AI-Powered All-in-One Tech Ecosystem for Dental Practices

DentTracks Unveils AI-Powered All-in-One Tech Ecosystem for Dental Practices

New Cloud-Based Solution Replaces Fragmented Tools to Drive Growth, Efficiency, and Profitability HOUSTON, TX, UNITED STATES, June 5, 2025 /⁨EINPresswire.com⁩/ -- DentTracks today announced the official launch of its proprietary AI-powered, cloud-based …

Xilio Therapeutics Announces Closing of $50.0 Million Public Offering

Xilio Therapeutics Announces Closing of $50.0 Million Public Offering

Total gross proceeds of up to $150.0 million before the end of 2026 if all Series B warrants and Series C warrants are exercised for cash Xilio may elect to cancel unexercised Series B or Series C warrants proportionately to the amount of non-dilutive …

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes

CHARLOTTE, N.C., June 05, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced it has priced an offering (the “Offering”) of $550 million aggregate principal amount of its 8.375% Junior …

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on June 2, …

Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified …

ImPact Biotech Announces Treatment of First Patient in Phase 1 Clinical Trial of Padeliporfin VTP in Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma (PDAC)

ImPact Biotech Announces Treatment of First Patient in Phase 1 Clinical Trial of Padeliporfin VTP in Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma (PDAC)

–  Previously inoperable patient converted to eligible for resection, underwent pancreaticoduodenectomy, following single course of treatment with Padeliporfin VTP  – TEL AVIV, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- ImPact Biotech, a clinical-stage …

Vireo Growth Inc. Announces Closing of Proper Brands Acquisition in Missouri

Vireo Growth Inc. Announces Closing of Proper Brands Acquisition in Missouri

MINNEAPOLIS , June 05, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), today announced that it has closed its previously-announced transaction to acquire Missouri-based Proper Brands (“Proper”) through the …

Hapbee Announces Shares-for-Debt Settlement

Hapbee Announces Shares-for-Debt Settlement

VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), the digital wellness technology company, announces that it has arranged to settle an aggregate of $ …

AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™

AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™

VALENCIA, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the first clinical publication evaluating Cohealyx™, an …

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on June 1, 2025 the Company granted inducement awards to purchase up …

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on June 1, 2025, it awarded …

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted inducement awards consisting of non-qualified stock options to …

Hydro One and ACT Foundation celebrate more than 25,000 students trained in lifesaving skills

Hydro One and ACT Foundation celebrate more than 25,000 students trained in lifesaving skills

LINDSAY, Ontario, June 05, 2025 (GLOBE NEWSWIRE) -- Today, the Advanced Coronary Treatment (ACT) Foundation joined Hydro One Inc. (Hydro One) and partners at I.E. Weldon Secondary School in Lindsay to mark the milestone of more than 25,000 Haliburton – …

Hydro One et la Fondation ACT célèbrent la formation de plus de 25 000 élèves aux techniques de secourisme

Hydro One et la Fondation ACT célèbrent la formation de plus de 25 000 élèves aux techniques de secourisme

LINDSAY, Ontario, 05 juin 2025 (GLOBE NEWSWIRE) -- Aujourd’hui, la Fondation des soins avancés en urgence coronarienne (ACT) s’est jointe à Hydro One Inc. (Hydro One) et à ses partenaires de l’école secondaire I.E. Weldon à Lindsay pour souligner le jalon …

MEDIROM Healthcare Technologies Inc. Regains Compliance with NASDAQ Continued Listing Requirements

MEDIROM Healthcare Technologies Inc. Regains Compliance with NASDAQ Continued Listing Requirements

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (“MEDIROM” or the “Company”), today announced that on June 4, 2025, it received a written notification from The …

Nanotechnology in Cancer Treatment Market Positioned for Transformational Growth by 2029

Nanotechnology in Cancer Treatment Market Positioned for Transformational Growth by 2029

Boston, June 05, 2025 (GLOBE NEWSWIRE) -- As cancer prevalence continues to rise globally, nanotechnology in cancer treatment is emerging as a transformative force in oncology. Leveraging nanoscale drug delivery systems and precision-targeting techniques, …

FDA Approved Anticancer Peptide Drug Conjugate Market Clinical Trials Insight

FDA Approved Anticancer Peptide Drug Conjugate Market Clinical Trials Insight

Delhi, June 05, 2025 (GLOBE NEWSWIRE) -- Global Peptide Drug Conjugate Market, Drug Sales, Price, Dosage and Clinical Trials Insight 2030 Report Highlights: Global Peptide Drug Conjugate Market Opportunity: > USD 1400 Million Global Peptide Drug Conjugate …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions